Targeting VPS4 elicits STING-driven anti-tumor immunity to suppress rhabdomyosarcoma growth. - Zhang R; Chen L; Liang X; Zhang J; Hamamoto K; Hattori T; Vangala V; Schell TD; Saulnier Sholler G; Takahashi Y; Wang HG (Oncogene, 2026)